Prévisions du marché des systèmes d’administration transdermique de médicaments au Moyen-Orient et en Afrique jusqu’en 2030 – Analyse régionale – par type (patchs transdermiques, gel transdermique, sprays transdermiques et autres), application (maladies cardiovasculaires, troubles du système nerveux central, gestion de la douleur, applications hormonales et autres Applications) et canal de distribution (pharmacies d\'hôpitaux, pharmacies de détail, pharmacies en ligne et autres)
Prévalence croissante de Les maladies chroniques renforcent le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique. Les maladies cardiovasculaires (MCV) telles que l\'angine de poitrine, l\'athérosclérose, le pectoris et l\'infarctus aigu du myocarde comptent parmi les causes courantes de mortalité dans le monde. Selon l’OMS, les maladies cardiovasculaires sont la principale cause d’environ 17,9 millions de décès dans le monde chaque année. De nombreux médicaments sont disponibles dans le commerce pour le traitement des maladies cardiovasculaires, mais les gélules et comprimés conventionnels sont incapables de contrôler efficacement la maladie. Cela souligne la nécessité de nouveaux systèmes d\'administration de médicaments offrant une biodisponibilité prolongée des médicaments et une administration ciblée des médicaments dans les zones affectées du système cardiovasculaire. Les systèmes d\'administration transdermique de médicaments offrent de nombreux avantages par rapport aux médicaments administrés par voie orale pour traiter les maladies cardiovasculaires. Des patchs transdermiques, contenant des particules médicamenteuses, sont appliqués à la surface de la peau. Un patch cardiaque constitue une excellente plate-forme pour l’amélioration de la greffe de cellules. Par exemple, un patch cardiaque vascularisé développé récemment présente un potentiel prometteur pour le traitement des lésions cardiaques ischémiques. Les patchs transdermiques de nitroglycérine sont utilisés pour prévenir les épisodes d\'angine (douleurs thoraciques) chez les personnes atteintes d\'une maladie coronarienne. Ils agissent en relaxant les vaisseaux sanguins et en réduisant le stress sur le cœur, réduisant ainsi le besoin en oxygène. Cependant, ces patchs ne peuvent pas être utilisés pour traiter les crises d’angine déjà commencées. Le patch Rivastigmine est utilisé pour traiter la démence (perte de mémoire) associée à la maladie d\'Alzheimer légère, modérée ou sévère ou à la démence légère à modérée associée à la maladie de Parkinson. La rivastigmine et le donépézil sont des inhibiteurs de la cholinestérase présentant une relation dose-réponse, des doses plus élevées des médicaments démontrant une plus grande efficacité. Il s’agit d’une petite molécule lipophile et hydrophile chimiquement bien adaptée à l’administration transdermique.
Le diabète est une maladie chronique potentiellement mortelle et sans traitement spécialisé. Les deux types de diabète peuvent entraîner divers problèmes dans différentes parties du corps et augmenter le risque global de décès prématuré. Selon les rapports de la 10e édition de l\'Atlas du diabète de la Fédération internationale du diabète (FID), en 2021, 537 millions d\'adultes (20-79 ans) dans le monde étaient diabétiques, et ce nombre devrait atteindre 643 millions d\'ici 2030 et 783 millions d\'ici 2045. est généralement administré par voie sous-cutanée pour la gestion du diabète. Cependant, l\'attention récente portée à un patch intelligent qui délivre de l\'insuline en cas de besoin, simplifiant ainsi la prise d\'insuline et activant une action ciblée.
Ainsi, l\'incidence croissante de maladies chroniques telles que les maladies cardiovasculaires, la maladie d\'Alzheimer et le diabète renforce la croissance du marché des systèmes d\'administration transdermique de médicaments. Aperçu du marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique. Le marché des systèmes d\'administration transdermique de médicaments dans la MEA est segmenté entre les Émirats arabes unis, l\'Arabie saoudite, l\'Afrique du Sud et le reste de la MEA. La croissance du marché devrait s’accentuer en raison de la forte prévalence des maladies chroniques, de l’augmentation des dépenses de santé et de l’augmentation des activités de R&D dans la région. De plus, la demande croissante de dispositifs médicaux technologiquement avancés contribue à propulser la croissance du marché au cours de la période de prévision. Selon une étude « Maladies non transmissibles et réponses du système de santé en Arabie Saoudite : focus sur les politiques et les stratégies. Une étude qualitative », publiée par Health Research Policy and Systems en 2022, les maladies non transmissibles (MNT), en particulier le diabète, les maladies cardiovasculaires et d\'autres maladies chroniques. maladies, sont responsables d’une maladie et d’un fardeau économique croissants en Arabie Saoudite. Selon les statistiques du ministère saoudien de la Santé, les maladies cardiovasculaires représentent 37 % de tous les décès en Arabie saoudite. Selon le Fonds des Nations Unies pour la population (FNUAP), la population vieillissante de l\'Arabie saoudite devrait quintupler, passant de 2 millions (5,9 %) en 2020 à 10,5 millions d\'ici 2050 (23,7 %). La population gériatrique est sujette à des problèmes de santé tels que les maladies cardiovasculaires, les infections pulmonaires et le diabète. Selon les données sur la charge mondiale de morbidité publiées en 2020, l’Arabie saoudite connaît une forte prévalence de maladies non transmissibles telles que les accidents vasculaires cérébraux, les maladies cardiaques, les maladies rénales, la BPCO et le diabète. En outre, les décès liés au diabète ont augmenté d\'environ 79 %, les maladies rénales chroniques de 41,2 % et les accidents vasculaires cérébraux de 27,6 % entre 2009 et 2019. Ainsi, la forte prévalence des maladies mentionnées alimente la demande de systèmes d\'administration transdermique de médicaments, stimulant ainsi le marché. croissance. L\'Arabie saoudite s\'est associée aux institutions universitaires et de recherche britanniques en 2019 pour une initiative de 1,6 milliard de dollars visant à renforcer les capacités nationales de recherche et de développement du Royaume. En Arabie Saoudite, en raison de la demande croissante de services de santé, les initiatives gouvernementales croissantes favorisent une participation accrue du secteur privé à leur expansion. Ainsi, la prévalence croissante des maladies cardiovasculaires dans la population et l’augmentation des dépenses de santé en Arabie Saoudite jouent un rôle essentiel dans la croissance du marché des systèmes d’administration transdermique de médicaments.
Revenus et prévisions du marché des systèmes d\'administration de médicaments transdermiques au Moyen-Orient et en Afrique jusqu\'en 2030 (en millions de dollars américains)
Segmentation du marché des systèmes d\'administration de médicaments transdermiques au Moyen-Orient et en Afrique
Le marché des systèmes d\'administration de médicaments transdermiques au Moyen-Orient et en Afrique est segmenté en type, application, canal de distribution et pays.
En fonction du type, le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique est segmenté en patchs transdermiques, gel transdermique, sprays transdermiques et autres. Le segment des gels transdermiques détenait la plus grande part du marché des systèmes d’administration transdermique de médicaments au Moyen-Orient et en Afrique en 2022. Les patchs transdermiques sont en outre sous-segmentés en patchs médicamenteux adhésifs, patchs matriciels, patchs à membrane de réservoir et patchs de vapeur.
En termes d\'application, le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique est classé en maladies cardiovasculaires, troubles du système nerveux central, gestion de la douleur, applications hormonales et autres applications. Le segment de la gestion de la douleur détenait la plus grande part du marché des systèmes d’administration transdermique de médicaments au Moyen-Orient et en Afrique en 2022. La gestion de la douleur est en outre sous-segmentée en opioïdes et non opioïdes. Les applications hormonales sont en outre sous-segmentées en thérapie transdermique aux œstrogènes et à la progestérone et en remplacement de la testostérone.
Par canal de distribution, le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique est segmenté en pharmacies hospitalières, pharmacies de détail, pharmacies en ligne et autres. Le segment des pharmacies hospitalières détenait la plus grande part du marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique en 2022.
En fonction du pays, le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique est classé dans les Émirats arabes unis, l\'Arabie saoudite et l\'Afrique du Sud. , et le reste du Moyen-Orient et de l\'Afrique. L\'Arabie saoudite a dominé le marché des systèmes d\'administration transdermique de médicaments au Moyen-Orient et en Afrique en 2022.
Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Novartis AG et Viatris Inc font partie des principales sociétés opérant dans ce pays. le marché des systèmes d’administration transdermique de médicaments au Moyen-Orient et en Afrique.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transdermal Drug Delivery System Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type
6.1 Overview
6.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis
9.1 Middle East & Africa Transdermal Drug Delivery System Market
9.1.1 Middle East & Africa Transdermal Drug Delivery System Market, by Country
9.1.1.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.1.3.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.1.4 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.1.4.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.1.4.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.1.5 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.3.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.4 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.4.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.4.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.5 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.3.3.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.3.4 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.3.4.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.3.4.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.3.5 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.3.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation
Table 2. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 27. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 28. Glossary of Terms, Middle East & Africa Transdermal Drug Delivery System Market
?
List of Figures
Figure 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. Middle East & Africa Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Middle East & Africa Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Middle East & Africa Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Transdermal Drug Delivery System Market
1. Boehringer Ingelheim International GmbH
2. GSK Plc
3. Hisamitsu Pharmaceutical Co Inc
4. Johnson & Johnson
5. Novartis AG
6. Viatris Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Transdermal Drug Delivery System Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.